Skip to ContentSkip to Navigation
About us Latest news News News articles

The role of the farnesoid X receptor in metabolic control

20 April 2011

PhD ceremony: Ms. J.H.M. Stroeve, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Title: The role of the farnesoid X receptor in metabolic control

Promotor(s): prof. F. Kuipers, prof. B. Staels

Faculty: Medical Sciences

 

Obesity increases the risk of serious health problems, including metabolic diseases such as the metabolic syndrome, cardiovascular diseases and type 2 diabetes. The subject of this thesis was to study the role of the so-called farnesoid X receptor (FXR) in regulating various metabolic processes including those of bile acids, sugars and fats. First, the relative contribution of FXR in the intestine to the regulation of hepatic bile acid production has been determined in mice. Then the consequences of FXR-deficiency on the metabolism of bile acids, sugars and fats were studied in mouse models of obesity. Finally, the role of FXR in the development and functioning of adipose tissue was examined. Together, the results indicate that FXR is an interesting starting point to influence the regulation of various metabolic processes.

 

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.